69,95 €
69,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
35 °P sammeln
69,95 €
69,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
35 °P sammeln
Als Download kaufen
69,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
35 °P sammeln
Jetzt verschenken
69,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
35 °P sammeln
  • Format: PDF

This volume is the first text to concisely yet comprehensively cover developments for both alcoholic and non-alcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies.
Written by experts in the field, Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.
…mehr

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 12.97MB
Produktbeschreibung
This volume is the first text to concisely yet comprehensively cover developments for both alcoholic and non-alcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies.

Written by experts in the field, Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Drs. Chalasani and Szabo are senior investigators in the field of fatty liver disease and have had extensive federal funding to investigate these areas. They both hold leadership positions and are recognized as experts in the field of fatty liver disease. For example, Dr. Chalasani is the lead author of the multi-society practice guideline on the diagnosis and management of nonalcoholic fatty liver disease& Dr. Szabo is the president-elect of the American Association for the Study of Liver Disease which is the largest liver society in the world. They are also actively practicing clinicians and thus aware of clinically relevant knowledge gaps in the field.
Rezensionen
"The purpose is to serve as a review of both mechanisms of liver disease. The book is meant to compare the two unique diseases, which share several mechanisms. ... The book summarizes current knowledge and contains updates on recent research. ... This is a high quality resource on the topic of alcoholic and nonalcoholic fatty liver disease, providing an in-depth discussion of the mechanisms ... ." (Ryan R. Sefcik, Doody's Book Reviews, June, 2016)